Scientific Programme

The Future Of HBV Functional Cure

Back

Free Paper Session
Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24-week interim data of the Phase 3 MYR301 study – Mr. Jacques YU

2 June 2022
3.50pm – 4.05pm